Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations
Open accessAbstract
Introduction: Cerebral autosomal‐dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a relatively common cerebral small vessel disease. NOTCH3 has been identified as the causative gene of CADASIL. Clinical variability and genetic heterogeneity were observed in CADASIL patients and need to be further clarified. Aims: The aim of the study was to clarify genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients. Methods: Suspected CADASIL patients were collected by our center between 2016 and 2021. Whole exome sequencing was performed to screen NOTCH3 mutations of these patients. Genetic and clinical data of CADASIL patients from previous studies were also analyzed. Studies between 1998 and 2021 that reported more than 9 pedigrees with detailed genetic data or clinical data were included. After excluding patients carrying cysteine‐sparing mutations, genetic data of 855 Asian pedigrees (433 Chinese; 226 Japanese, and 196 Korean) and 546 Caucasian pedigrees, in a total of 1401 CADASIL pedigrees were involved in mapping mutation spectrum. Clinical data of 901 Asian patients (476 Chinese patients, 217 Japanese patients, and 208 Korean patients) and 720 Caucasian patients, in a total of 1621 patients were analyzed and compared between different populations. Results: Two novel mutations (c.400T>C, p.Cys134Arg; c.1511G>A, p.Cys504Tyr) and 24 known cysteine‐affecting variants were identified in 36 pedigrees. Genetic spectrums of Asians (Chinese, Japanese, and Korean) and Caucasians were clarified, p.R544C and p.R607C were the most common mutations in Asians while p.R1006C and p.R141C in Caucasians. For clinical features, Asians were more likely to develop symptoms of TIA or ischemic stroke (p < 0.0001) and cognitive impairment (p < 0.0001). Nevertheless, Caucasians had a higher tendency to present migraine (p < 0.0001) and psychiatric disturbance (p < 0.0001). The involvement of temporal pole was more likely to happen in Caucasians (p < 0.0001). Conclusion: The findings help to better understand the clinical variability and genetic heterogeneity of CADASIL.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CADASIL in Asian patients often lacks classic radiologic phenotype, such as anterior temporal pole involvement, and may present later in life with confluent WMHs and cognitive impairment, increasing the risk of misdiagnosis.
“Moreover, CADASIL in Asian patients often lacks classic radiologic phenotype, such as anterior temporal pole involvement, and may present later in life with confluent WMHs and cognitive impairment, increasing the risk of misdiagnosis.16-18”
From Multiple Sclerosis Misdiagnosis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (2026) · cites this paper as [16]
The Results (Clinical features of CADASIL patients in different populations; page unavailable) report later age at onset, more cognitive impairment, and less frequent temporal-pole involvement in Asian than Caucasian patients, though temporal-pole involvement still occurred in 68.64% of Asian patients. The Introduction describes white matter hyperintensities, but our copy does not establish that they are confluent or that this presentation increases misdiagnosis risk. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088 · see citing works
<scp>CADASIL</scp> and <scp>CARASIL</scp>
Tikka, S., Baumann, M., Siitonen, M., Pasanen, P., Pöyhönen, M., Myllykangas, L., Viitanen, M., Fukutake, T., Cognat, E., Joutel, A., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12181 · Cited by 189 · see citing works
CADASIL: a review with proposed diagnostic criteria
Davous, P. (1998) · European Journal of Neurology · doi:10.1046/j.1468-1331.1998.530219.x · Cited by 161 · see citing works
Characteristics of CADASIL in Korea: A novel cysteine-sparing Notch3 mutation
Kim, Y., Choi, E. J., Choi, C. G., Kim, G., Choi, J. H., Yoo, H. W., & Kim, J. S. (2006) · Neurology · doi:10.1212/01.wnl.0000216259.99811.50 · Cited by 98 · see citing works
Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue
Mizuno, T., Muranishi, M., Torugun, T., Tango, H., Nagakane, Y., Kudeken, T., Kawase, Y., Kawabe, K., Oshima, F., Yaoi, T., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1391 · Cited by 49 · see citing works
Flagged first, then by citations
Research works printed but not linked: 21
- [1]Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult‐onset condition causing stroke and dementia. Nature. 1996; 383(6602): 707‐ 710. 8878478
- [2]Tikka S, Baumann M, Siitonen M, et al. CADASIL and CARASIL. Brain Pathol. 2014; 24(5): 525‐ 544. 25323668 PMC8029192
- [3]Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000; 105(5): 597‐ 605. 10712431 PMC289174
- [4]Schoemaker D, Arboleda‐Velasquez JF. Notch3 signaling and aggregation as targets for the treatment of CADASIL and other NOTCH3‐associated small‐vessel diseases. Am J Pathol. 2021; 191(11): 1856‐ 1870. 33895122 PMC8647433
- [5]Stojanov D, Vojinovic S, Aracki‐Trenkic A, et al. Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Bosn J Basic Med Sci. 2015; 15(1): 1‐ 8. PMC4365670 25725137
- [6]O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001; 56(5): 628‐ 634. 11245715
- [7]Chen S, Ni W, Yin XZ, et al. Clinical features and mutation spectrum in Chinese patients with CADASIL: a multicenter retrospective study. CNS Neurosci Ther. 2017; 23(9): 707‐ 716. 28710804 PMC6492642
- [9]Xie JJ, Ni W, Wei Q, et al. New clinical characteristics and novel pathogenic variants of patients with hereditary leukodystrophies. CNS Neurosci Ther. 2020; 26(5): 567‐ 575. 31885218 PMC7163788
- [10]Jiang B, Zhou J, Li HL, et al. Mutation screening in Chinese patients with familial Alzheimer's disease by whole‐exome sequencing. Neurobiol Aging. 2019; 76: 215.e15‐ 215.e21. 30598257
- [11]Dong HL, Ma Y, Yu H, et al. Bi‐allelic loss of function variants in COX20 gene cause autosomal recessive sensory neuronopathy. Brain. 2021; 144(8): 2457‐ 2470. 33751098
- [12]Dong Y, Ni W, Chen WJ, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson's disease guides genetic diagnosis. Theranostics. 2016; 6(5): 638‐ 649. 27022412 PMC4805659
- [14]Liao YC, Hsiao CT, Fuh JL, et al. Characterization of CADASIL among the Han Chinese in Taiwan: distinct genotypic and phenotypic profiles. PloS ONE. 2015; 10(8): e0136501. 26308724 PMC4550240
- [15]Min JY, Park SJ, Kang EJ, Hwang SY, Han SH. Mutation spectrum and genotype‐phenotype correlations in 157 Korean CADASIL patients: a multicenter study. Neurogenetics. 2022; 23(1): 45‐ 58. 34741685
- [16]Hu Y, Sun Q, Zhou Y, et al. NOTCH3 variants and genotype‐phenotype features in Chinese CADASIL patients. Front Genet. 2021; 12: 705284. 34335700 PMC8320595
- [17]Zhang C, Li S, Li W, Niu S, Wang X, Zhang Z. Genotypic and phenotypic characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy from China. Eur Neurol. 2021; 84(4): 237‐ 245. 34004599
- [18]Chabriat H, Joutel A, Dichgans M, Tournier‐Lasserve E, Bousser MG. Cadasil. Lancet Neurol. 2009; 8(7): 643‐ 653. 19539236
- [19]Paraskevas GP, Stefanou MI, Constantinides VC, et al. CADASIL in Greece: mutational spectrum and clinical characteristics based on a systematic review and pooled analysis of published cases. Eur J Neurol. 2022; 29(3): 810‐ 819. 34761493
- [21]Kim H, Lim YM, Lee EJ, Oh YJ, Kim KK. Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine‐sparing NOTCH3 mutations. PloS ONE. 2020; 15(6): e0234797. 32555735 PMC7302479
- [22]Ueda A, Ueda M, Nagatoshi A, et al. Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014. J Neurol. 2015; 262(8): 1828‐ 1836. 25980907
- [24]Mizuta I, Koizumi T, Mukai M, Watanabe‐Hosomi A, Mizuno T. Cysteine‐sparing variations of NOTCH3 found on genetic test for CADASIL. J Neurol Sci. 2017; 381: 458.
- [25]Choi BW, Park S, Kim HJ. Possible role of a missense mutation of p.P167S on NOTCH3 gene associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Dement Neurocogn Disord. 2016; 15(2): 52‐ 54. 30906341 PMC6427975
Cited by
Sorted by citations
Mendis, D. D., Vallamchetla, S. K., Marin Collazo, I. V., Sandhu, S. J. S., & Meschia, J. F. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200430
- Authors
- Ni, W., Zhang, Y., Zhang, L., Xie, J., Li, H., & Wu, Z.
- Affiliations
- Department of Neurology and Department of Medical Genetics in the Second Affiliated Hospital, and Key Laboratory of Medical Neurobiology of Zhejiang Province Zhejiang University School of Medicine Hangzhou China
- Second Affiliated Hospital of Zhejiang University (CN)
- Corresponding author
- Wu, Zhi‐Ying
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2022-07-13
- Volume
- 28
- Issue
- 11
- Pages
- 1779-1789
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- PMC
- PMC9532899
- OpenAlex
- W4285086584
- Cited by
- 36
- References
- 6
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 1
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- CNS Neuroscience & Therapeutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- CADASIL, NOTCH3 mutations, mutation spectrum, genetic heterogeneity, clinical phenotype, cerebral small vessel disease, novel mutations, ischemic stroke, migraine, cognitive impairment, psychiatric disturbances, temporal lobe involvement, leukoencephalopathy, white matter lesions, genetic counseling, genotype-phenotype correlation
- MeSH terms
- Receptor, Notch3, Cysteine, Humans, Magnetic Resonance Imaging, Mutation, Phenotype, CADASIL, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review